🚚 Free Worldwide Shipping on All Orders!Shop Now
1 / 6
Wegovy 2.4mg flextouch 1 pen
Wegovy (2.4mg) is a weight loss medication approved by the FDA that helps you control your appetite and lose weight. It is a once-weekly, prefilled injection pen FlexTouch®. It belongs to the class of GLP‑1 receptor agonists, mimicking the natural hormone GLP‑1 which helps control appetite and enhance feelings of fullness.
Benefits:
- Aids significant weight loss and long-term weight control in adults with obesity (BMI ≥ 30 kg/m²) or overweight individuals (BMI ≥ 27 kg/m²) with associated health conditions.
- Helps reduce the risk of serious heart-related events in adults with cardiovascular disease.
- Approved for weight management in adolescents aged 12 and older with obesity (weight over 60 kg), when lifestyle adjustments alone are insufficient.
Main Ingredient & Its Benefits:
- Semaglutide: A synthetic GLP‑1 agonist that promotes satiety, reduces appetite, slows gastric emptying, supports weight reduction, and metabolic improvements.
Benefits:
- Aids significant weight loss and long-term weight control in adults with obesity (BMI ≥ 30 kg/m²) or overweight individuals (BMI ≥ 27 kg/m²) with associated health conditions.
- Helps reduce the risk of serious heart-related events in adults with cardiovascular disease.
- Approved for weight management in adolescents aged 12 and older with obesity (weight over 60 kg), when lifestyle adjustments alone are insufficient.
Main Ingredient & Its Benefits:
- Semaglutide: A synthetic GLP‑1 agonist that promotes satiety, reduces appetite, slows gastric emptying, supports weight reduction, and metabolic improvements.
$92.56
Original: $308.52
-70%Wegovy 2.4mg flextouch 1 pen—
$308.52
$92.56Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Wegovy (2.4mg) is a weight loss medication approved by the FDA that helps you control your appetite and lose weight. It is a once-weekly, prefilled injection pen FlexTouch®. It belongs to the class of GLP‑1 receptor agonists, mimicking the natural hormone GLP‑1 which helps control appetite and enhance feelings of fullness.
Benefits:
- Aids significant weight loss and long-term weight control in adults with obesity (BMI ≥ 30 kg/m²) or overweight individuals (BMI ≥ 27 kg/m²) with associated health conditions.
- Helps reduce the risk of serious heart-related events in adults with cardiovascular disease.
- Approved for weight management in adolescents aged 12 and older with obesity (weight over 60 kg), when lifestyle adjustments alone are insufficient.
Main Ingredient & Its Benefits:
- Semaglutide: A synthetic GLP‑1 agonist that promotes satiety, reduces appetite, slows gastric emptying, supports weight reduction, and metabolic improvements.
Benefits:
- Aids significant weight loss and long-term weight control in adults with obesity (BMI ≥ 30 kg/m²) or overweight individuals (BMI ≥ 27 kg/m²) with associated health conditions.
- Helps reduce the risk of serious heart-related events in adults with cardiovascular disease.
- Approved for weight management in adolescents aged 12 and older with obesity (weight over 60 kg), when lifestyle adjustments alone are insufficient.
Main Ingredient & Its Benefits:
- Semaglutide: A synthetic GLP‑1 agonist that promotes satiety, reduces appetite, slows gastric emptying, supports weight reduction, and metabolic improvements.
